Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Return on Capital %

Gilead Sciences Inc Return on Capital % Chart (GILD)

Gilead Sciences Inc annual/quarterly Return on Capital % from 2010 to 2020.
  • Gilead Sciences Inc Return on Capital % for the quarter ending June 06, 2020 was 8.70 a 188.67% increase of 16.42 year over year
  • Gilead Sciences Inc Return on Capital % for the last 12 months ending June 06, 2020 was 5.69 a -24.29% decrease of -1.38 year over year
  • Gilead Sciences Inc Annual Return on Capital % for 2019 was 6.57 a -66.85% decrease of -4.39 from 2018
  • Gilead Sciences Inc Annual Return on Capital % for 2018 was 10.96 a -61.53% decrease of -6.74 from 2017
  • Gilead Sciences Inc Annual Return on Capital % for 2017 was 17.70 a -46.86% decrease of -8.29 from 2016
Other Margins & Efficiency Metrics:
  • Gilead Sciences Inc EBITDA Margin for the quarter ending December 12, 2018 was $26m a -90.33% decrease of -23m year over year
  • Gilead Sciences Inc Return on Equity % for the quarter ending December 12, 2018 was 0.05 a -55,717.16% decrease of -29.86 year over year
View Chart On Koyfin

Quarterly GILD Return on Capital % Data

06/20208.70
03/202012.74
12/201910.07
09/2019-7.72
06/201913.16
03/201911.41
12/20189.90
09/201812.97
06/201811.34
03/201810.38

Annual GILD Return on Capital % Data

20196.57
201810.96
201717.70
201625.99
201539.97
201440.87
201315.61
201216.66
201119.83
201028.70